New Enterprise Associates 16, L.P.

New Enterprise Associates 16, L.P. is listed in filings as 10% Owner at Trevi Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 13, 2026, including purchase activity. Recent filings connect the profile to Trevi Therapeutics, Inc. (TRVI) and Marker Therapeutics, Inc. (MRKR). The current snapshot covers public activity from Dec 23, 2024 to Feb 13, 2026. Reported amounts are shown as $2.5M to $1.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.